Study of Patterns of Cutaneous Manifestations in Patients Receiving Radiotherapy: A Cross-Sectional Study
Main Article Content
Background and objectives: Radiation therapy is associated with various cutaneous manifestations which may have a severe impact on the quality of life as well as cancer treatment. Hence, it is important to identify the adverse reactions to radiation therapy for assessment and management of the severity of disease. The present study aimed to evaluate the spectrum of cutaneous adversities in patients undergoing radiotherapy.
Materials and Method: This cross-sectional prospective study was conducted on 97 patients with internal malignancies, for approximately 2 years. Clinical history of the patients was collected during the study. The cutaneous features of all the patients were studied clinically and relevant investigations such as potassium hydroxide examination, Tzanck test, Gram’s stained smear, hematological and biochemical investigations, skiagrams, venereal disease research laboratory test, and skin biopsy were conducted when required. In addition, radiation dosage, total radiation cycles, duration of treatment, and clinical diagnosis of radiation-induced skin changes were recorded. Chi-Square test was used to check the association between attributes. P value less than or equal to 0.05 was considered statistically significant.
Results: Grade 1 acute radiation dermatitis was found in majority of the subjects. Statistically significant associations between radiotherapy-induced cutaneous adverse effects and gender (p<0.004), radiotherapy-induced side effects and involved site of primary underlying malignancy (p=0.015), and radiotherapy cycles and cutaneous adverse effects (p=0.001) were observed Maximum cases of adverse effects were observed for doses between 3001 cGy and 4000 cGy with a. significant association between the side effects and dosages (p=0.002).
Conclusion: Acute radiation dermatitis was the most common side effect of definitive radiotherapy in this study. Therefore, it necessitates active intervention by a multidisciplinary group to manage both the acute and late effects of radiotherapy on the skin and subcutaneous tissues.
Khanna NR, Kumar DP, Laskar SG, Laskar S. Radiation dermatitis: An overview. Indian J Burns 2013;21(1):24-31.
Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, et al. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol 2010;17(4):94–112.
McQuestion M. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 2011;27(2):e1–17.
Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage 2005;30(5):433–42.
Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A review of our current understanding. Am J Clin Dermatol 2016;17(3):277-92.
Hymes SR, Strom EA, Fife C. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment. J Am Acad Dermatol 2006;54(1):28-46.
Pommier P, Gomez F, Sunyach MP, Hombres AD, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004;22(8):1447-53.
National Cancer Institute, Division of Cancer Treatment and Diagnosis Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v4.0. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_4.03.xlsx. Accessed on July 07, 2020.
Bolderston A, Lloyd NS, Wong RKS, Holden L, Robb-Blenderman L, Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer 2006;14(8):802–17.
Ryan JL. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol. 2012;132(3 Pt 2):985–93.
McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs 2006;22(3):163–73.
Thanik VD, Chang CC, Zoumalan RA, Lerman OZ, Allen Jr RJ, Nguyen PD, et al. A novel mouse model of cutaneous radiation injury. Plast Reconstr Surg 2011;127(2):560-8.
Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, et al. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 2006;65(3):890-8.
Chopra S, Sharma V, Nischal KC, Khopkar U, Baisane C, Amare KP. Darrier’s disease following radiotherapy for carcinoma of cervix. Indian J Dermatol Venereol Leprol 2004;70(5):300-3.
Polat M, Yalcin B, Alli N. Vitiligo at the site of radiotherapy for nasopharyngeal carcinoma. Am J Clin Dermatol 2007;8(4):247-9.
Mul VEM, Van Geest AJ, Pijls-Johannesma MCG, Theys J, Verschueren TAM, Jager JJ, et al. Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol 2007;82(1):5-9.
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ooga S, Abe M, et al. Erythema multiforme and Stevens-Johnson syndrome following radiotherapy. Radiat Med 2007;25(1):27-30.
Maryum H, Ahmed S, Talat H, Khan RS, Gitay M, Hameed A. Acute versus chronic radio dermatitis with ionizing radiation: A comparative study of their frequency of presentation. Prof Med J 2018;25(6):842-6.
Saini S, Pai V, Shukla P, Ranglani H. A study of clinical patterns of acute radiation dermatitis among patients attending dermatology outpatient department at tertiary center in Western India. Clin Dermatol Rev 2018;2(1):8-12.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous‑cell carcinoma of the head and neck. N Engl J Med 2006;354(6):567‑78.
Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, et al. The incidence of postoperative radiotherapy-induced dermatitis in breast cancer and its influencing factors for Chinese women. Onco Targets Ther 2018;11:1665-70.
Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogenic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 2007;15(5):491-6.
Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006;106(2):329-36.